colloidal carriers
TRANSCRIPT
-
8/7/2019 Colloidal carriers
1/22
Delivery and targeting of TherapeuticProteins using Colloidal CarrierParticles
-
8/7/2019 Colloidal carriers
2/22
Colloidal Carrier Systems They are particles that are used as drug carriers into which
drugs or antigens may be incorporated in the form ofsolutions or dispersions or onto which these materials maybe adsorbed or chemically bound.
These particles have been shown to enhance the delivery ofcertain drugs across a number of natural and artificialmembranes.
They are basically Nanoparticles ranging in size from 10nm to 1000 nm (1 m). They consist of macromolecularmaterials in which the active principle (drug or biologicallyactive material) is dissolved, entrapped, or encapsulated,and/or to which the active material is adsorbed or attached.
-
8/7/2019 Colloidal carriers
3/22
-
8/7/2019 Colloidal carriers
4/22
Liposomes
-
8/7/2019 Colloidal carriers
5/22
Liposomes Their exterior lipid bilayer is very chemically reactive, thereby providing a
means to conveniently couple tags on a covalent basis.
Such tags can be antibodies, antigens, cell receptors, nucleic acidprobes, etc.
This provides significant versatility in assay formats (i.e., immunoassay,receptor-based, nucleic acid probe, etc.) possible.
With diameters ranging in size from approximately 50 nm to 800 nm, theiraqueous core encapsulates up to millions of molecules of signalgenerating markers that can be detected in a variety of different way.
A variety of different encapsulants are possible including visuallydetectable dyes (since the lipid bilayer is transparent), optically andfluorometrically detectable dyes, enzymes, and electroactive compounds.
This provides significant versatility in the detection schemes possible.
-
8/7/2019 Colloidal carriers
6/22
Micelles
-
8/7/2019 Colloidal carriers
7/22
Micelles
Micelle is an aggregate of amphipathic molecules in water, with thenonpolar portions in the interior and the polar portions at the exteriorsurface, exposed to water.
Amphiphilic molecules form micelle above a particular concentrationwhich is called as critical micellar concentration (CMC).
Micelles are known to have an anisotropic water distribution within theirstructure, means water concentration decreases from the surfacetowards the core of the micelle, with a completely hydrophobic (water-excluded) core.
Hydrophobic drugs can be encapsulated/solublized, into inner core.
The spatial position of a solubilized drug in a micelle will depend on itspolarity, nonpolar molecules will be solubilized in the micellar core, andsubstances with intermediate polarity will be distributed along thesurfactant molecules in certain intermediate positions.
-
8/7/2019 Colloidal carriers
8/22
Dendrimers
-
8/7/2019 Colloidal carriers
9/22
Dendrimers
These branched macromolecules are constructed around asimple core unit.
Dendrimers have a high degree of molecular uniformity,narrow molecular weight distribution, specific size and shapecharacteristics, and a highly-functionalizedterminal surface.
The manufacturing process is a series of repetitive steps
starting with a central initiator core. Each subsequent growthstep represents a new "generation" of polymer with a largermolecular diameter, twice the number of reactive surfacesites, and approximately double the molecular weight of thepreceding generation.
-
8/7/2019 Colloidal carriers
10/22
Carbon 60 (C60)
-
8/7/2019 Colloidal carriers
11/22
Carbon 60 (C60)
C60 are spherical molecules about 1nm in diameter,comprising 60 carbon atomsarranged as 20 hexagons and 12 pentagons: the
configuration of a football. Hence they find application as NanoPharmaceuticals with
large drug payload in their cage like structure.
On the other hand with development of various chemicalsubstitutes for C60, it is possible to develop functionalized C60with better drug targeting properties
-
8/7/2019 Colloidal carriers
12/22
Carbon Nanotube
-
8/7/2019 Colloidal carriers
13/22
Carbon Nanotube
Carbon nanotubes are adept at entering the nuclei of cellsand may one day be used to deliver drugs and vaccines.
The modified nanotubes have so far only been used to ferry a
small peptide into the nuclei of fibroblast cells.
But the researchers are hopeful that the technique may oneday form the basis for new anti-cancer treatments, genetherapies and vaccines.
-
8/7/2019 Colloidal carriers
14/22
Polymeric Nanoparticles
-
8/7/2019 Colloidal carriers
15/22
-
8/7/2019 Colloidal carriers
16/22
Quantum Dots
-
8/7/2019 Colloidal carriers
17/22
Quantum Dots Consists of a semiconductor core (CdSe), coated by a shell
(e.g., ZnS) to improve optical properties, and a cap enablingimproved solubility in aqueous buffers.
Properties originate from their physical size, which rangesfrom 10100 in radius.
Due to their bright fluorescence, narrow emission, broad UVexcitation and high photostability, they have been adopted forin vitro bioimaging for real time monitoring or tracking ofintracellular process for longer time.
Large impact on some important development in differentmedical areas like diagnostic tools, MRI, in vitro and in vivodetection and analysis of biomolecules, immunoassays,DNA hybridization, non-viral vectors for gene therapy,transport vehicles for DNA, protein, drugs or cells,
fluorescence imaging of tissue, and as therapeutic tools forcancer treatment.
-
8/7/2019 Colloidal carriers
18/22
Advantages increased surface area
enhanced solubility
increased rate of dissolution
increased oral bioavailability
more rapid onset of therapeutic action
less amount of dose required decreased fed/fasted variability
decreased patient-to-patient variability
-
8/7/2019 Colloidal carriers
19/22
CHALLENGES
Prevention of drug from biological degradation
Effective Targeting
Patient Compliance
Cost effectiveness
Product life extension
-
8/7/2019 Colloidal carriers
20/22
Methods of Drug Delivery
-
8/7/2019 Colloidal carriers
21/22
Applications of variousnanosystems in cancer therapy
-
8/7/2019 Colloidal carriers
22/22
Thank You!